Pharma-Bio Serv, Inc.
PBSV
$0.60
-$0.09-13.03%
OTC PK
| 07/31/2025 | 04/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -18.78% | -2.20% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -18.78% | -2.20% | |||
| Cost of Revenue | -13.11% | -6.16% | |||
| Gross Profit | -29.85% | 6.59% | |||
| SG&A Expenses | -3.15% | 6.59% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -9.48% | -1.88% | |||
| Operating Income | -219.33% | -6.62% | |||
| Income Before Tax | -307.14% | 940.21% | |||
| Income Tax Expenses | -187.27% | 400.00% | |||
| Earnings from Continuing Operations | -314.15% | 1,022.35% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -314.15% | 1,022.35% | |||
| EBIT | -219.33% | -6.62% | |||
| EBITDA | -274.97% | 3.99% | |||
| EPS Basic | -311.90% | 950.00% | |||
| Normalized Basic EPS | -311.11% | 800.00% | |||
| EPS Diluted | -325.00% | 900.00% | |||
| Normalized Diluted EPS | -311.11% | 800.00% | |||
| Average Basic Shares Outstanding | -0.03% | -0.10% | |||
| Average Diluted Shares Outstanding | -0.03% | -0.07% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||